Telemedicine catches ROP, NEI study finds

Article

A National Eye Institute (NEI) study found that telemedicine can effectively screen for retinopathy of prematurity (ROP) and could potentially ease the strain on hospitals with limited access to ophthalmologists.

A National Eye Institute (NEI) studyfound that telemedicine can effectively screen for retinopathy of prematurity (ROP) and could potentially ease the strain on hospitals with limited access to ophthalmologists.

Second Sight, Kellog Eye Center finding early success with artificial retina

The study evaluated telemedicine for ROP screening during the care of 1,257 premature babies. Every nine days or so, each infant was screened by an ophthalmologist, who assessed whether referral treatment was warranted. Either immediately before or after that exam, a staff member took photos of babies’ eyes, which were sent to a secure server at the University of Oklahoma, Oklahoma City for evaluation by staff who were trained to recognize signs of severe ROP. The staff then made recommendations on whether the infant should be referred to an eyecare professional for further treatment.

The non-physician image readers in Oklahoma City correctly identified 90 percent of the infants that needed a referral based on examination by an ophthalmologist, and they correctly identified 87 percent of the infants who did not need a referral. The examining ophthalmologists documented 244 infants with ROP who needed a referral on exam, 162 of whom were treated. Of these, non-physician image readers identified ROP that warranted a referral in all but three infants (98 percent).

According to NEI, some signs of ROP appear in about half of infants born at or before 30 weeks, but only five to eight percent of those cases become severe enough to require treatment. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
© 2025 MJH Life Sciences

All rights reserved.